Literature DB >> 3883191

Autocrine growth factors and cancer.

M B Sporn, A B Roberts.   

Abstract

The ability of cancer cells to produce and to respond to their own growth factors (autocrine secretion) has become a central concept linking oncogene and growth factor research. Oncogenes confer growth factor autonomy on cells not only by coding directly for autocrine peptide growth factors or their receptors, but also by amplifying the mitogenic signals generated by a growth factor at its receptor. Antagonists of positive autocrine growth factors can inhibit growth of cancer cells in experimental animals. Recently identified negative autocrine growth factors might themselves control aberrant cell growth.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3883191     DOI: 10.1038/313745a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  282 in total

Review 1.  Structural cues from the tissue microenvironment are essential determinants of the human mammary epithelial cell phenotype.

Authors:  K L Schmeichel; V M Weaver; M J Bissell
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-04       Impact factor: 2.673

2.  Inhibitory effects of EGFR antisense oligodeox ynucleotide in human colorectal cancer cell line.

Authors:  Yong He; Jun Zhou; Jin-Sheng Wu; Ke-Feng Dou
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

3.  IGF-I stimulates proliferation of spontaneously immortalized human keratinocytes (HACAT) by autocrine/paracrine mechanisms.

Authors:  G Pozzi; M Guidi; F Laudicina; M Marazzi; L Falcone; R Betti; C Crosti; E E Müller; G E DiMattia; V Locatelli; A Torsello
Journal:  J Endocrinol Invest       Date:  2004-02       Impact factor: 4.256

Review 4.  Animal models for the biological effects of continuous high cytokine levels.

Authors:  M Lübbert; D Jonas; F Herrmann
Journal:  Blut       Date:  1990-11

5.  Interleukin 1-dependent paracrine granulopoiesis in chronic granulocytic leukemia of the juvenile type.

Authors:  G C Bagby; C A Dinarello; R C Neerhout; D Ridgway; E McCall
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

6.  Integration of the BALB/c ecotropic provirus into the colony-stimulating factor-1 growth factor locus in a myc retrovirus-induced murine monocyte tumor.

Authors:  W R Baumbach; E M Colston; M D Cole
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

7.  Heparin-treated, v-myc-transformed chicken heart mesenchymal cells assume a normal morphology but are hypersensitive to epidermal growth factor (EGF) and brain fibroblast growth factor (bFGF); cells transformed by the v-Ha-ras oncogene are refractory to EGF and bFGF but are hypersensitive to insulin-like growth factors.

Authors:  S D Balk; T M Riley; H S Gunther; A Morisi
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

8.  Establishment of the DU.528 human lymphohemopoietic stem cell line.

Authors:  J Kurtzberg; S H Bigner; M S Hershfield
Journal:  J Exp Med       Date:  1985-11-01       Impact factor: 14.307

9.  Immunocytochemical study of transforming growth factor expression in benign and malignant gliomas.

Authors:  V Samuels; J M Barrett; S Bockman; C G Pantazis; M B Allen
Journal:  Am J Pathol       Date:  1989-04       Impact factor: 4.307

10.  Regulation of adhesion and growth of fibrosarcoma cells by NF-kappa B RelA involves transforming growth factor beta.

Authors:  J R Perez; K A Higgins-Sochaski; J Y Maltese; R Narayanan
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.